Haruaki Nakaya. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AgedAmiodarone/administration & dosageAnti-Arrhythmia Agents/administration & dosageC-Reactive Protein/biosynthesisCardiomyopathy, Dilated/drug therapyCardiomyopathy, Dilated/metabolismCells, CulturedChemokine CCL2/biosynthesisFemaleGene Expression Regulation/drug effectsHumansLeukocytes, Mononuclear/metabolismMaleMiddle AgedRecovery of Function/drug effectsStroke Volume/drug effectsTachycardia, Ventricular/drug therapyTachycardia, Ventricular/metabolismTime FactorsTumor Necrosis Factor-alpha/biosynthesis
Substances: See more » Anti-Arrhythmia AgentsCCL2 protein, humanChemokine CCL2Tumor Necrosis Factor-alphaC-Reactive ProteinAmiodarone
Year: 2009 PMID: 19318723 DOI: 10.1253/circj.cj-09-0038
Source DB: PubMed Journal: Circ J ISSN: 1346-9843 Impact factor: 2.993